Mill Road Capital III, L.P.
Known title: 10% OwnerCIK: 0001767199
Mill Road Capital III, L.P.'s purchase track record
How the stock did after each of Mill Road Capital III, L.P.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
14
of 14 since June 30, 2022
Stock higher 6 months later
43%
3 months: 57%
Median 6-month return
-12.5%
3 months: +0.4%
Beat the S&P 500
36%
median -21.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/11/2026 | ALTG | $492K | +0.3% | -7.2% | +12.7% |
| 7/31/2024 | ALTG | $1.69M | -37.2% | -31.9% | +9.4% |
| 7/10/2024 | ALTG | $1.44M | -26.6% | -17.8% | +5.1% |
| 4/26/2023 | NDLS | $500K | -24.9% | -51.8% | +3.2% |
| 4/6/2023 | NDLS | $8K | -35.2% | -50.5% | +3.7% |
| 3/29/2023 | NDLS | $23K | -23.8% | -50.3% | +6.1% |
| 3/17/2023 | NDLS | $464K | -29.9% | -45.2% | +13.6% |
| 12/21/2022 | NDLS | $563K | +0.6% | -33.5% | +12.6% |
| 10/7/2022 | NDLS | $81K | +19.9% | +4.5% | +12.9% |
| 9/22/2022 | NDLS | $338K | +8.5% | +7.4% | +5.1% |
| 9/1/2022 | NDLS | $1.06M | +20.3% | +28.9% | +0.4% |
| 7/26/2022 | NDLS | $511K | +33.9% | +36.2% | +2.5% |
| 7/12/2022 | NDLS | $680K | +8.2% | +22.5% | +2.6% |
| 6/30/2022 | NDLS | $1.43M | +1.1% | +17.0% | +1.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
ALTG Shares Fall Amid Mixed Analyst Views. ALTG shares fell in the last week as several analysts highlighted headwinds. A Yahoo article noted that the stock is trading near its 13‑touch support level of $6.24 and has a high beta. Other reports point out that while some view the company as a potential pick, others advise caution. The stock remains within its 52‑week range of $4.16 to $8.69.
Transaction History
| NDLS | ▼ Sell | Other | 7,103 | $0 | 5/15/2026 | View on chart |
| ALTG | ▲ Buy | Open Market | 3,798 | $23K | 3/13/2026 | View on chart |
| ALTG | ▲ Buy | Open Market | 58,162 | $355K | 3/12/2026 | View on chart |
| ALTG | ▲ Buy | Open Market | 18,040 | $115K | 3/11/2026 | View on chart |
| NDLS | ▼ Sell | Other | 36,000 | $0 | 5/15/2025 | View on chart |
| ALTG | ▼ Sell | Other | 23,700 | $237K | 1/17/2025 | View on chart |
| ALTG | ▼ Sell | Other | 20,600 | $206K | 12/19/2024 | View on chart |
| ALTG | ▼ Sell | Other | 500 | $5K | 12/18/2024 | View on chart |
| ALTG | ▼ Sell | Other | 200 | $2K | 12/17/2024 | View on chart |
| ALTG | ▼ Sell | Other | 35,000 | $350K | 12/16/2024 | View on chart |
| ALTG | ▼ Sell | Other | 41,200 | $515K | 9/20/2024 | View on chart |
| ALTG | ▼ Sell | Other | 1,100 | $11K | 9/20/2024 | View on chart |
| ALTG | ▼ Sell | Other | 5,600 | $70K | 8/16/2024 | View on chart |
| ALTG | ▼ Sell | Other | 14,900 | $149K | 8/15/2024 | View on chart |
| ALTG | ▼ Sell | Other | 86,700 | $1.1M | 8/15/2024 | View on chart |
| ALTG | ▲ Buy | Open Market | 54,200 | $495K | 8/2/2024 | View on chart |
| ALTG | ▲ Buy | Open Market | 40,014 | $409K | 8/1/2024 | View on chart |
| ALTG | ▲ Buy | Open Market | 75,486 | $781K | 7/31/2024 | View on chart |
| ALTG | ▲ Buy | Open Market | 179,414 | $1.4M | 7/10/2024 | View on chart |
| ALTG | ▼ Sell | Other | 151,600 | $1.5M | 7/1/2024 | View on chart |
| ALTG | ▼ Sell | Other | 33,700 | $337K | 6/27/2024 | View on chart |
| ALTG | ▼ Sell | Other | 31,600 | $395K | 6/13/2024 | View on chart |
| ALTG | ▼ Sell | Other | 4,900 | $49K | 6/3/2024 | View on chart |
| ALTG | ▼ Sell | Other | 6,200 | $78K | 5/29/2024 | View on chart |
| NDLS | ▼ Sell | Other | 27,027 | $0 | 5/15/2024 | View on chart |
| NDLS | ▼ Sell | Other | 17,800 | $89K | 11/17/2023 | View on chart |
| NDLS | ▼ Sell | Other | 1,900 | $10K | 10/20/2023 | View on chart |
| NDLS | ▼ Sell | Other | 200 | $1K | 9/29/2023 | View on chart |
| NDLS | ▼ Sell | Other | 7,000 | $35K | 9/19/2023 | View on chart |
| NDLS | ▼ Sell | Other | 169,200 | $846K | 9/18/2023 | View on chart |
| NDLS | ▼ Sell | Other | 245,500 | $1.8M | 9/13/2023 | View on chart |
| NDLS | ▼ Sell | Other | 70,700 | $354K | 9/7/2023 | View on chart |
| NDLS | ▼ Sell | Other | 100 | $500 | 9/5/2023 | View on chart |
| NDLS | ▼ Sell | Other | 60,100 | $301K | 8/31/2023 | View on chart |
| NDLS | ▼ Sell | Other | 32,600 | $163K | 8/30/2023 | View on chart |
| NDLS | ▼ Sell | Other | 9,100 | $68K | 8/30/2023 | View on chart |
| NDLS | ▼ Sell | Other | 2,200 | $11K | 8/29/2023 | View on chart |
| NDLS | ▼ Sell | Other | 142,100 | $711K | 8/28/2023 | View on chart |
| NDLS | ▼ Sell | Other | 29,569 | $82K | 8/28/2023 | View on chart |
| NDLS | ▼ Sell | Other | 14,100 | $71K | 8/21/2023 | View on chart |
| NDLS | ▼ Sell | Other | 2,000 | $10K | 8/16/2023 | View on chart |
| NDLS | ▼ Sell | Other | 500 | $4K | 5/24/2023 | View on chart |
| NDLS | ▼ Sell | Other | 18,800 | $141K | 5/23/2023 | View on chart |
| NDLS | ▼ Sell | Other | 12,900 | $97K | 5/22/2023 | View on chart |
| NDLS | ▼ Sell | Other | 12,500 | $94K | 5/19/2023 | View on chart |
| NDLS | ▼ Sell | Other | 3,800 | $29K | 5/18/2023 | View on chart |
| NDLS | ▼ Sell | Other | 139,000 | $1.0M | 5/16/2023 | View on chart |
| NDLS | ▼ Sell | Other | 2,600 | $20K | 5/15/2023 | View on chart |
| NDLS | ▼ Sell | Other | 2,500 | $19K | 5/12/2023 | View on chart |
| NDLS | ▼ Sell | Other | 53,000 | $398K | 5/11/2023 | View on chart |
| NDLS | ▲ Buy | Open Market | 107,439 | $500K | 4/26/2023 | View on chart |
| NDLS | ▼ Sell | Other | 6,900 | $52K | 4/25/2023 | View on chart |
| NDLS | ▼ Sell | Other | 2,800 | $21K | 4/24/2023 | View on chart |
| NDLS | ▲ Buy | Open Market | 1,833 | $8K | 4/6/2023 | View on chart |
| NDLS | ▲ Buy | Open Market | 5,000 | $23K | 3/29/2023 | View on chart |
| NDLS | ▲ Buy | Open Market | 100,000 | $464K | 3/17/2023 | View on chart |
| NDLS | ▲ Buy | Open Market | 6,411 | $32K | 12/23/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 45,333 | $223K | 12/22/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 61,986 | $308K | 12/21/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 17,290 | $81K | 10/7/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 31,265 | $144K | 9/26/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 10,244 | $46K | 9/23/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 32,612 | $148K | 9/22/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 131,085 | $596K | 9/6/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 61,739 | $285K | 9/2/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 40,057 | $184K | 9/1/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 9,473 | $43K | 7/27/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 103,898 | $468K | 7/26/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 2,435 | $11K | 7/14/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 143,221 | $669K | 7/12/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 61,132 | $292K | 7/5/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 144,931 | $674K | 7/1/2022 | View on chart |
| NDLS | ▲ Buy | Open Market | 98,656 | $460K | 6/30/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Noodles & Company Expands to Las Cruces, New Mexico
Noodles & Company has opened its first restaurant in New Mexico, located in Las Cruces. This expansion marks a new geographic milestone for the chain. The stock is currently trading near its lower support levels, reflecting a cautious market sentiment despite the growth news.
Noodles & Company Expands to Las Cruces, New Mexico. Noodles & Company has opened its first restaurant in New Mexico, located in Las Cruces. This expansion marks a new geographic milestone for the chain. The stock is currently trading near its lower support levels, reflecting a cautious market sentiment despite the growth news.